Literature DB >> 22607571

Correlation of coronary artery calcification with pre-hemodialysis bicarbonate levels in patients on hemodialysis.

Machiko Oka1, Takayasu Ohtake, Yasuhiro Mochida, Kunihiro Ishioka, Kyoko Maesato, Hidekazu Moriya, Sumi Hidaka, Shuzo Kobayashi.   

Abstract

Coronary artery calcification (CAC) leads to a significant increase in cardiovascular morbidity and mortality in hemodialysis (HD) patients. Metabolic acidosis, which is common in HD patients, promotes bone resorption in human and animals as a result of buffer function of bone, and calcium and phosphate elute from bone into blood stream. However, the effect of acidosis on CAC in HD patients has never been precisely investigated. This is a cross-sectional observational study performed in a single center. One hundred and seven prevalent HD patients (35 women and 72 men) underwent electron-beam computed tomography (EBCT) to evaluate CAC score (CACS), and then we evaluated associated factors of CACS with clinical and laboratory parameters including pre-HD pH and bicarbonate levels. Pre-HD pH and bicarbonate levels were 7.35 ± 0.04, and 17.6 ± 1.8 mmol/L, respectively. The pre-HD pH had no significant correlation to CACS (r = -0.025, P = 0.81). CACS was significantly negatively correlated with pre-HD bicarbonate levels (r = -0.329, P = 0.0009) and serum albumin levels (r = -0.298, P = 0.0467), while it was positively correlated with age (r = 0.319, P = 0.0008) and HD duration (r = 0.385, P = 0.0004). Serum levels of calcium, phosphorus, intact parathyroid hormone, and use of phosphorus binders were not related to CACS. Multivariate analysis indicated that plasma pre-HD bicarbonate level was independently associated with CACS. The present study showed that blood levels of pre-HD bicarbonate were significantly associated with CAC in HD patients. Further studies are needed to confirm these results and to determine whether correction of metabolic acidosis prevents the development of CAC, one of the features of accelerated atherosclerosis in HD patients.
© 2012 The Authors. Therapeutic Apheresis and Dialysis © 2012 International Society for Apheresis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607571     DOI: 10.1111/j.1744-9987.2011.01054.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  12 in total

1.  High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

Authors:  Hartmut H Malluche; Gustav Blomquist; Marie-Claude Monier-Faugere; Thomas L Cantor; Daniel L Davenport
Journal:  J Am Soc Nephrol       Date:  2015-04-02       Impact factor: 10.121

2.  Metabolic acidosis status and mortality in patients on the end stage of renal disease.

Authors:  Vaia D Raikou
Journal:  J Transl Int Med       Date:  2016-12-30

3.  Correlation between serum parathyroid hormone levels and coronary artery calcification in patients without renal failure.

Authors:  Gang-Yong Wu; Bai-Da Xu; Ting Wu; Xiao-Ying Wang; Tian-Xiao Wang; Xiao Zhang; Xiao Wang; Yang Xia; Gang-Jun Zong
Journal:  Biomed Rep       Date:  2016-09-26

4.  Pathophysiologic Changes in Extracellular pH Modulate Parathyroid Calcium-Sensing Receptor Activity and Secretion via a Histidine-Independent Mechanism.

Authors:  Katherine L Campion; Wanda D McCormick; Jim Warwicker; Mohd Ezuan Bin Khayat; Rebecca Atkinson-Dell; Martin C Steward; Leigh W Delbridge; Hee-Chang Mun; Arthur D Conigrave; Donald T Ward
Journal:  J Am Soc Nephrol       Date:  2015-01-02       Impact factor: 10.121

5.  Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.

Authors:  Andreas Pasch; Geoffrey A Block; Matthias Bachtler; Edward R Smith; Wilhelm Jahnen-Dechent; Spyridon Arampatzis; Glenn M Chertow; Patrick Parfrey; Xiaoye Ma; Juergen Floege
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

6.  The role of oral sodium bicarbonate supplementation in maintaining acid-base balance and its influence on the cardiovascular system in chronic hemodialysis patients - results of a prospective study.

Authors:  C Voiculeț; O Zară; C Bogeanu; I Văcăroiu; G Aron
Journal:  J Med Life       Date:  2016 Oct-Dec

Review 7.  Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification.

Authors:  Shuzo Kobayashi
Journal:  Ann Vasc Dis       Date:  2017-03-31

8.  Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis.

Authors:  Teruko Nakamura; Taisei Fujisaki; Motoaki Miyazono; Maki Yoshihara; Hiroshi Jinnouchi; Kenichi Fukunari; Yuki Awanami; Yuki Ikeda; Kohei Hashimoto; Masatora Yamasaki; Yasunori Nonaka; Makoto Fukuda; Tomoya Kishi; Yuji Ikeda
Journal:  Drugs R D       Date:  2018-09

9.  Acid-base balance in uremic rats with vascular calcification.

Authors:  Alan Peralta-Ramírez; Ana Isabel Raya; Carmen Pineda; Mariano Rodríguez; Escolástico Aguilera-Tejero; Ignacio López
Journal:  Nephron Extra       Date:  2014-07-02

Review 10.  Modifying Phosphate Toxicity in Chronic Kidney Disease.

Authors:  Marc Vervloet
Journal:  Toxins (Basel)       Date:  2019-09-09       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.